The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX

BJU International

Volumn 86, Issue 1, 2000, Pages 126-132

  Gronlund Pakkanen S ^a,c   Pakkanen, T M ^a   Talja, M ^a   Kosma, V M ^b   Ala Opas, M ^a   Alhava, E ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aminolaevulinic acid; Morphological changes; Photodynamic therapy; Urinary bladder

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; BLADDER INJURY; BLADDER WALL; DETRUSOR MUSCLE; FEMALE; MICROSCOPY; MORPHOLOGY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY;

AMINOLEVULINIC ACID; ANIMALS; FEMALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RATS; RATS, WISTAR; URINARY BLADDER DISEASES;

EID: 0033919071     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00718.x     Document Type: Article

References (27)

1. 1 Manyak MJ. Photodynamic therapy: principles and urologic applications. Semin Urol 1991; 9: 192-202
2. 2 Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-92
3. 3 Pope AJ, Bown SG. Photodynamic therapy. Br J Urol 1991; 68: 1-9
4. 4 Grönlund-Pakkanen S, Mäkinen K, Talja M et al. The importance of fluorescence distribution and kinetics of ALA-induced PpIX in the bladder in photodynamic therapy. J Photochem Photobiol B-Biol 1997; 38: 269-73
5. 5 Bedwell J, MacRobert AJ, Phillips D et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer 1992; 65: 818-24
6. 6 Leveckis J, Burn JL, Brown NJ et al. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. J Urol 1994; 152: 550-3
7. 7 Loh CS, MacRobert AJ, Bedwell J et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993; 68: 41-51
8. 8 Mäkinen K, Grönlund-Pakkanen S, Tiirikainen M et al. Protoporphyrin-IX distribution and photodynamic effect in rat oesophagus after aminolaevulinic acid administration. Scand J Gastroenterol 1997; 32: 633-7
9. 9 Loh CS, Vernon D, MacRobert AJ et al. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B 1993; 20: 47-54
10. 10 Xiao Z, Miller GG, McCallum TJ et al. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy. Photochem Photobiol 1998; 67: 573-83
11. 11 Chang SC, Buonaccorsi G, MacRobert AJ et al. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration. Lasers Surg Med 1997; 20: 254-64
12. 12 Kriegmair M, Baumgartner R, Lumper W et al. Early clinical experience with 5-aminolaevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol 1996; 77: 667-71
13. 13 Nseyo UO, DeHaven J, Dougherty TJ et al. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. J Clin Laser Med Surg 1998; 16: 61-8
14. 14 Pope AJ, Bown SG. The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. J Urol 1991; 145: 1064-70
15. 15 Ash DV, Brown SB. New drugs and future developments in photodynamic therapy. Eur J Cancer 1993; 29A: 1781-3
16. 16 Prout GR Jr, Lin CW, Benson R Jr et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N Engl J Med 1987; 317: 1251-5
17. 17 Dougherty TJ, Marcus SL. Photodynamic therapy. Eur J Cancer 1992; 28A: 1734-42
18. 18 Iinuma S, Bachor R, Flotte T et al. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol 1995; 153: 802-6
19. 19 Nseyo UO. Photodynamic therapy in the management of bladder cancer. J Clin Laser Med Surg 1996; 14: 271-80
20. 20 Stocker S, Knuchel R, Sroka R et al. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid. J Urol 1997; 157: 357-61
21. 21 Nseyo UO. Photodynamic therapy. Urol Clin North Am 1992; 19: 591-9
22. 22 Baghdassarian R, Wright MW, Vaughn SA et al. The use of lipid emulsion as an intravesical medium to disperse light in the potential treatment of bladder tumors. J Urol 1985; 133: 126-30
23. 23 Hisazumi H, Miyoshi N, Naito K et al. Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: a preliminary report. J Urol 1984; 131: 884-7
24. 24 Marynissen JP, Jansen H, Star WM. Treatment system for whole bladder wall photodynamic therapy with in vivo monitoring and control of light dose rate and dose. J Urol 1989; 142: 1351-5
25. 25 van Staveren HJ, Bertrams RH, Star WM. Bladder PDT with intravesical clear and light scattering media: effect of an eccentric isotropic light source on the light distribution. Lasers Surg Med 1997; 20: 248-53
26. 26 Taari K, Talja M, Riihelä M et al. Morphological effects of photodynamic therapy on rabbit bladder using Photofrin II and Photosan intravesically and intravenously. Br J Urol 1992; 70: 616-21
27. 27 Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX. basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-8